We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$257K
Cap. Flow
+$12.2M
Cap. Flow %
5.15%
Top 10 Hldgs %
35.07%
Holding
477
New
382
Increased
34
Reduced
30
Closed
12

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$3.72M
2
AMZN icon
Amazon
AMZN
+$3.54M
3
NKE icon
Nike
NKE
+$3.34M
4
PG icon
Procter & Gamble
PG
+$3.32M
5
COST icon
Costco
COST
+$3.26M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$5.83M
2
ZTO icon
ZTO Express
ZTO
+$5.15M
3
EDU icon
New Oriental
EDU
+$4.58M
4
LI icon
Li Auto
LI
+$4.42M
5
CTLT
CATALENT, INC.
CTLT
+$3.94M

Sector Composition

Rank Sector Weight
1 Technology 36.45%
2 Consumer Discretionary 23.79%
3 Healthcare 23.76%
4 Communication Services 3.6%
5 Consumer Staples 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
151
BioCryst Pharmaceuticals
BCRX
$2.71B
$22K 0.01%
+1,741
New +$22.4K
SAGE
152
DELISTED
Sage Therapeutics
SAGE
$22K 0.01%
+556
New +$21.5K
ZLAB icon
153
Zai Lab
ZLAB
$2.86B
$22K 0.01%
+650
New +$27.8K
EW icon
154
Edwards Lifesciences
EW
$53.6B
$21K 0.01%
256
-11,465
-98% -$1.1M
XENE icon
155
Xenon Pharmaceuticals
XENE
$6.31B
$21K 0.01%
+583
New +$21K
FATE icon
156
Fate Therapeutics
FATE
$317M
$20K 0.01%
+909
New +$26.3K
LEGN icon
157
Legend Biotech
LEGN
$3.99B
$20K 0.01%
+499
New +$23.4K
ISEE
158
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$20K 0.01%
+1,106
New +$14.5K
IBRX icon
159
ImmunityBio
IBRX
$8.2B
$19K 0.01%
+3,749
New +$17.1K
TWST icon
160
Twist Bioscience
TWST
$7.85B
$19K 0.01%
+528
New +$22.4K
VERV
161
DELISTED
Verve Therapeutics
VERV
$19K 0.01%
+561
New +$17.9K
RVNC
162
DELISTED
Revance Therapeutics, Inc.
RVNC
$18K 0.01%
+684
New +$13.9K
AXSM icon
163
Axsome Therapeutics
AXSM
$11.2B
$17K 0.01%
+377
New +$18.8K
KRYS icon
164
Krystal Biotech
KRYS
$9.85B
$17K 0.01%
+240
New +$17.3K
LYEL icon
165
Lyell Immunopharma
LYEL
$347M
$17K 0.01%
+116
New +$15.7K
SUPN icon
166
Supernus Pharmaceuticals
SUPN
$2.78B
$17K 0.01%
+501
New +$16.3K
RVMD icon
167
Revolution Medicines
RVMD
$44B
$16K 0.01%
+821
New +$18K
RXRX icon
168
Recursion Pharmaceuticals
RXRX
$1.76B
$16K 0.01%
+1,547
New +$15.7K
AGIO icon
169
Agios Pharmaceuticals
AGIO
$2.04B
$15K 0.01%
+513
New +$13.8K
ALLO icon
170
Allogene Therapeutics
ALLO
$714M
$15K 0.01%
+1,347
New +$18.3K
IQV icon
171
IQVIA
IQV
$39.8B
$15K 0.01%
84
– –
IRWD icon
172
Ironwood Pharmaceuticals
IRWD
$714M
$15K 0.01%
+1,435
New +$16.3K
TVTX icon
173
Travere Therapeutics
TVTX
$5.86B
$15K 0.01%
+599
New +$15.5K
XNCR icon
174
Xencor
XNCR
$1.72B
$15K 0.01%
+559
New +$16K
BBIO icon
175
BridgeBio Pharma
BBIO
$16.4B
$14K 0.01%
+1,388
New +$14.4K
5 6
7
8 9

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2022 Portfolio in Review

As of Q3 2022, China Universal Asset Management Company held 477 positions worth $238M, down 0.11% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company deployed $12.2M of net new capital in Q3 2022, opening 382 new positions and adding to 34 existing holdings. Its largest new stake was Home Depot: 12,599 shares worth $3.48M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was JD.com, an estimated $5.83M trimmed.

  • China Universal Asset Management Company's largest Q3 2022 buy was Home Depot: 12,599 shares worth $3.48M.
  • China Universal Asset Management Company added most to Amazon in Q3 2022, an estimated $3.54M increase.
  • China Universal Asset Management Company's biggest Q3 2022 reduction was JD.com, cutting an estimated $5.83M.
  • China Universal Asset Management Company fully exited ZTO Express in Q3 2022, selling an estimated $5.15M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $238M portfolio in Q3 2022.
  • China Universal Asset Management Company opened 382 new positions and closed 12 in Q3 2022.
  • China Universal Asset Management Company's portfolio value fell 0.11% quarter-over-quarter to $238M.

Based on China Universal Asset Management Company's 13F filing for Q3 2022, filed 21 Oct 2022.